ClinConnect ClinConnect Logo
Search / Trial NCT06005129

Personality Change Study for Borderline Personality Disorder

Launched by SHANNON E. SAUER-ZAVALA · Aug 16, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The "Personality Change Study for Borderline Personality Disorder" is looking for individuals with borderline personality disorder to participate in a clinical trial. This study aims to understand how effective a specific treatment can be in helping manage symptoms of the disorder. To start, participants will go through a 2 to 4-week assessment period without any treatment. This will help researchers measure their symptoms before starting the treatment. After this period, participants will attend six weekly sessions, each lasting about 50 to 60 minutes. After completing the sessions, there will be a 4-week follow-up to see how well the treatment worked and if the benefits last over time.

To be eligible for this study, participants need to be fluent in English and have a confirmed diagnosis of borderline personality disorder. However, those who have other psychological issues that might require different treatments, are currently in therapy, have unstable medication, or struggle with substance use disorders will not be able to join. This trial is currently recruiting individuals aged 65 to 74, and both men and women can participate. It's a chance for those who are eligible to contribute to research that could lead to better treatment options for borderline personality disorder.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Speak English fluently
  • Diagnosis of Borderline Personality Disorder
  • Exclusion Criteria:
  • diagnosed psychological conditions that would be better addressed by alternative treatments
  • concurrent psychotherapy
  • medication instability
  • substance use disorder

About Shannon E. Sauer Zavala

Shannon E. Sauer-Zavala is a distinguished clinical trial sponsor recognized for her commitment to advancing mental health research and therapeutic interventions. With a robust background in clinical psychology and a focus on innovative treatment methodologies, she leads initiatives that aim to enhance patient outcomes and contribute to the scientific understanding of psychological disorders. Her collaborative approach fosters partnerships with research institutions and healthcare providers, ensuring that trials are designed with rigor and ethical integrity. Through her leadership, Shannon is dedicated to translating research findings into practical applications that benefit diverse populations.

Locations

Lexington, Kentucky, United States

Patients applied

0 patients applied

Trial Officials

Shannon Sauer-Zavala, PhD

Principal Investigator

University of Kentucky

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported